MapLight Therapeutics, Inc.

MPLTNASDAQHealthcare● Active

$29.46

+$1.45(+5.18%)

Market Cap$23253897

P/E Ratio—

52W High$33.28

52W Low$12.24

Avg Volume283K

Open$28.40

Beta2.34

Earnings Financials Revenue

MapLight Therapeutics, Inc. (MPLT) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

MPLT · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2026Report Date: May 14, 2026

EPS Actual

-$1.34

Est. -$0.96 · -39.3%

Revenue

—

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 14, 2026

After Market Close

▼ Miss EPS

MPLT reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Sep 18, 2026	-$1.29	—	—	—	—	—
◌ Q3 FY2026	Aug 13, 2026	-$1.05	—	—	—	—	—
▼ Q2 FY2026	May 14, 2026	-$0.96	-$1.34	-39.3%	—	—	—
▼ Q4 FY2025	Dec 4, 2025	-$1.72	-$37.18	-2061.6%	—	—	—

Q3 FY2026

Sep 18, 2026

EPS Actual

—

EPS Est.

-$1.29

EPS Surpr.

—

Revenue

—

Q3 FY2026

Aug 13, 2026

EPS Actual

—

EPS Est.

-$1.05

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 14, 2026Miss

EPS Actual

-$1.34

EPS Est.

-$0.96

EPS Surpr.

-39.3%

Revenue

—

Q4 FY2025

Dec 4, 2025Miss

EPS Actual

-$37.18

EPS Est.

-$1.72

EPS Surpr.

-2061.6%

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2027	$-1.10	$-1.10	$-1.10	1
Q3 FY2027	$-1.10	$-1.10	$-1.10	1
Q2 FY2027	$-1.16	$-1.16	$-1.16	1
Q1 FY2027	$-1.20	$-1.20	$-1.20	1
Q4 FY2026	$-1.16	$-1.16	$-1.16	1
Q3 FY2026	$-1.37	$-1.17	$-1.04	5

Revenue Estimates

Period	Low	Consensus	High
Q4 FY2027	$0.0B	$0.0B	$0.0B
Q3 FY2027	$0.0B	$0.0B	$0.0B
Q2 FY2027	$0.0B	$0.0B	$0.0B
Q1 FY2027	$0.0B	$0.0B	$0.0B
Q4 FY2026	$0.0B	$0.0B	$0.0B
Q3 FY2026	$0.0B	$0.0B	$0.0B

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▼ Q2 FY2026	May 14, 2026	-39.3%	$30.67	$29.29	-4.50%
▼ Q4 FY2025	Dec 4, 2025	-2061.6%	$16.92	$18.34	+8.39%

Q2 FY2026-4.50%

Report Date

May 14, 2026

EPS Beat/Miss

-39.3%

Price Before

$30.67

Price After

$29.29

Q4 FY2025+8.39%

Report Date

Dec 4, 2025

EPS Beat/Miss

-2061.6%

Price Before

$16.92

Price After

$18.34

Avg Miss Reaction+1.95%

Beat Rate0 / 2 quarters

Largest Move+8.39% (Q4 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

MapLight Therapeutics, Inc. (MPLT) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-1.34 — missing the analyst consensus of $-0.96 by -39.3%. The next MPLT earnings date is expected around September 1, 2026.

Each quarter, investors track MPLT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MPLT revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

MPLT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

MPLT earnings · 5 questions

MapLight Therapeutics, Inc.'s next earnings report is expected around September 1, 2026. MPLT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MPLT historically reports after market close (AMC).

MPLT earnings datewhen is MPLT earningsMPLT next earnings datewhen does MPLT report earningsMPLT earnings calendar

▸ Source: FMP · MapLight Therapeutics, Inc. SEC filings · US GAAP · MapLight Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026